封面
市場調查報告書
商品編碼
1627983

聯合重建設備市場機會、成長動力、產業趨勢分析與預測 2024 - 2032

Joint Reconstruction Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 140 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球關節重建器材市場在 2023 年達到 196 億美元,預計 2024 年至 2032 年複合年成長率為 4.5%。人口老化以及骨關節炎和類風濕性關節炎等關節相關疾病的增加等因素推動了重建手術的需求。此外,由於健身和體育活動日益普及,年輕人中與運動相關的傷害增加,進一步提振了市場。

科技創新正在改變聯合重建設備的面貌。生物相容性材料、3D 列印和植入物設計的進步正在增強設備的耐用性和功能性,從而帶來更好的手術結果和患者滿意度。這些發展正在擴大聯合重建手術對不同年齡層的吸引力。

市場依關節類型分為膝關節、髖關節、肩關節、踝關節置換物及其他產品。膝關節置換市場預計將以5.1% 的複合年成長率成長,到2032 年將超過145 億美元。 ,特別是在老年人。由於對手術干預來解決進行性關節損傷的需求不斷增加,膝關節置換術仍然是首選的關節重建手術。

市場範圍
開始年份 2023年
預測年份 2024-2032
起始值 196 億美元
預測值 291 億美元
複合年成長率 4.5%

根據最終用途,市場分為醫院和診所、流動中心等。 2023 年,醫院和診所在這一領域佔據主導地位,預計到2032 年將達到207 億美元。的病例。他們全面的資源可以實現精確且有效率的手術,尤其是大型聯合手術。

2023 年,北美市場收入達105 億美元,2024 年至2032 年複合年成長率預計為3.4%。增加骨質疏鬆症。生活方式因素,包括高肥胖率和久坐習慣,也會導致關節退化,增加重建手術的需求。強大的醫療基礎設施和技術採用進一步支持北美市場的成長。

目錄

第 1 章:方法與範圍

第 2 章:執行摘要

第 3 章:產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 老年人口基數不斷增加
      • 骨科疾病盛行率增加
      • 技術進步
      • 關節重建手術的成長率
      • 需要個性化和患者特定的植入物
    • 產業陷阱與挑戰
      • 設備成本高
      • 嚴格的 FDA 法規
      • 術後併發症
  • 成長潛力分析
  • 技術景觀
  • 供應鏈分析
  • 未來市場趨勢
  • 監管環境
  • 報銷場景
  • 投資概況
  • 波特的分析
  • PESTEL分析

第 4 章:競爭格局

  • 介紹
  • 公司市佔率分析
  • 公司矩陣分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 戰略儀表板

第 5 章:市場估計與預測:按聯合類型,2021 - 2032

  • 主要趨勢
  • 膝關節置換術
    • 依產品
      • 主要膝關節系統
      • 部分膝關節系統
      • 膝關節翻修系統
    • 按成分
      • 股骨組件
      • 脛骨組件
      • 髕骨組件
  • 髖關節置換術
    • 依產品
      • 初級髖關節重建裝置
      • 髖關節重建修復裝置
      • 部分髖關節重建裝置
      • 髖關節表面置換設備
    • 按成分
      • 髖臼組件
      • 股骨組件
  • 肩關節置換術
    • 肩關節置換術表面置換植入物
    • 肩關節置換創傷植入物
    • 肩關節置換平台植入物
  • 踝關節置換術
    • 兩部件固定軸承
    • 三部件移動軸承
  • 其他接頭類型

第 6 章:市場估計與預測:依最終用途,2021 - 2032 年

  • 主要趨勢
  • 醫院和診所
  • ASC
  • 其他最終用戶

第 7 章:市場估計與預測:按地區分類,2021 - 2032 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 8 章:公司簡介

  • Aesculap Implant Systems
  • Allegra Orthopedic
  • Amplitude Ortho
  • Arthrex
  • CONMED
  • DJO Global
  • Exactech
  • Globus Medical
  • Integra LifeSciences
  • Johnson & Johnson
  • Medacta International
  • Microport
  • NuVasive
  • Smith & Nephew
  • Stryker
  • Zimmer Biomet
簡介目錄
Product Code: 2823

The Global Joint Reconstruction Devices Market reached USD 19.6 billion in 2023 and is projected to grow at a CAGR of 4.5% from 2024 to 2032. This growth is fueled by the increasing prevalence of joint disorders and injuries worldwide. Factors such as the aging population and the rise in joint-related conditions like osteoarthritis and rheumatoid arthritis drive demand for reconstructive procedures. Additionally, an uptick in sports-related injuries among younger demographics, fueled by the growing popularity of fitness and athletic activities, has further boosted the market.

Technological innovations are transforming the landscape of joint reconstruction devices. Advances in biocompatible materials, 3D printing, and implant design are enhancing the durability and functionality of devices, leading to better surgical outcomes and patient satisfaction. These developments are expanding the appeal of joint reconstruction surgeries across diverse age groups.

The market is segmented by joint type into knee, hip, shoulder, ankle replacements, and other products. The knee replacement segment is poised to grow at a CAGR of 5.1%, surpassing USD 14.5 billion by 2032. High demand in this segment stems from the widespread prevalence of knee-related conditions that impair mobility and quality of life, particularly among the elderly. Knee replacements remain the preferred joint reconstruction surgeries, driven by the increasing need for surgical interventions to address progressive joint damage.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$19.6 Billion
Forecast Value$29.1 Billion
CAGR4.5%

By end use, the market is categorized into hospitals & clinics, ambulatory centers, and others. Hospitals and clinics dominated the segment in 2023, projected to reach USD 20.7 billion by 2032. These facilities are preferred for joint reconstruction surgeries due to their ability to manage complex cases with advanced tools, robotic systems, and cutting-edge imaging technologies. Their comprehensive resources enable precise and efficient procedures, especially for major joint surgeries.

North America accounted for USD 10.5 billion in market revenue in 2023 and is set to grow at a CAGR of 3.4% from 2024 to 2032. The region's market expansion is primarily driven by the aging population, leading to a rise in joint conditions like osteoarthritis and osteoporosis. Lifestyle factors, including high obesity rates and sedentary habits, are also contributing to joint degeneration, increasing the demand for reconstruction procedures. Robust healthcare infrastructure and technological adoption further support market growth in North America.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing base of geriatric population
      • 3.2.1.2 Increasing prevalence of orthopedic diseases
      • 3.2.1.3 Technological advancements
      • 3.2.1.4 Growing rate of joint reconstruction surgeries
      • 3.2.1.5 Need for personalized and patient specific implants
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost of the devices
      • 3.2.2.2 Stringent FDA regulations
      • 3.2.2.3 Post-surgical complications
  • 3.3 Growth potential analysis
  • 3.4 Technology landscape
  • 3.5 Supply chain analysis
  • 3.6 Future market trends
  • 3.7 Regulatory landscape
  • 3.8 Reimbursement scenario
  • 3.9 Investment overview
  • 3.10 Porter's analysis
  • 3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Joint Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Knee replacement
    • 5.2.1 By product
      • 5.2.1.1 Primary knee systems
      • 5.2.1.2 Partial knee systems
      • 5.2.1.3 Revision knee systems
    • 5.2.2 By component
      • 5.2.2.1 Femoral component
      • 5.2.2.2 Tibial component
      • 5.2.2.3 Patellar component
  • 5.3 Hip Replacement
    • 5.3.1 By product
      • 5.3.1.1 Primary hip reconstruction devices
      • 5.3.1.2 Revision hip reconstruction devices
      • 5.3.1.3 Partial hip reconstruction devices
      • 5.3.1.4 Hip resurfacing devices
    • 5.3.2 By component
      • 5.3.2.1 Acetabular component
      • 5.3.2.2 Femoral component
  • 5.4 Shoulder Replacement
    • 5.4.1 Shoulder arthroplasty resurfacing implants
    • 5.4.2 Shoulder arthroplasty trauma implants
    • 5.4.3 Shoulder arthroplasty platform implants
  • 5.5 Ankle Replacement
    • 5.5.1 Two-component fixed bearing
    • 5.5.2 Three-component mobile bearing
  • 5.6 Other joint types

Chapter 6 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Hospitals & clinics
  • 6.3 ASCs
  • 6.4 Other end users

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Spain
    • 7.3.5 Italy
    • 7.3.6 Netherlands
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 South Korea
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
  • 7.6 Middle East and Africa
    • 7.6.1 South Africa
    • 7.6.2 Saudi Arabia
    • 7.6.3 UAE

Chapter 8 Company Profiles

  • 8.1 Aesculap Implant Systems
  • 8.2 Allegra Orthopedic
  • 8.3 Amplitude Ortho
  • 8.4 Arthrex
  • 8.5 CONMED
  • 8.6 DJO Global
  • 8.7 Exactech
  • 8.8 Globus Medical
  • 8.9 Integra LifeSciences
  • 8.10 Johnson & Johnson
  • 8.11 Medacta International
  • 8.12 Microport
  • 8.13 NuVasive
  • 8.14 Smith & Nephew
  • 8.15 Stryker
  • 8.16 Zimmer Biomet